NCT06500975View on ClinicalTrials.gov

Long Term Outcomes After Vestibular Implantation

NARecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Bilateral Vestibular HypofunctionBilateral Vestibular DeficiencyBilateral VestibulopathyGentamicin OtotoxicityAminoglycoside ToxicityVestibular DiseasesSensation DisordersLabyrinth DiseasesOther Disorders of Vestibular Function
Interventions
DEVICE

Labyrinth Devices MVI™ Multichannel Vestibular Implant System

Continuously motion-modulated stimulation delivered by a vestibular implant already implanted under a prior study protocol (Labyrinth Devices MVI™ Multichannel Vestibular Implant System)

Trial Locations (1)

21287

RECRUITING

Johns Hopkins School of Medicine, Baltimore

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

collaborator

Labyrinth Devices, LLC

OTHER

lead

Johns Hopkins University

OTHER